Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
2023 · Nature Communications · 31 citations
https://doi.org/10.1038/s41467-023-42400-5
B
Bianca Kraft
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
360
Citations
9
h-index
9
i10-index
Bianca Kraft is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Wnt/β-catenin signaling in development and cancer & Developmental Biology and Gene Regulation & Cancer Diagnosis and Treatment. The author has an h-index of 9, co-authored 23 publications.
ORCID: 0009-0009-6348-4819Papers by this author
worksRegulation of distinct branches of the non-canonical Wnt-signaling network in Xenopus dorsal marginal zone explants
2016 · BMC Biology · 8 citations
https://doi.org/10.1186/s12915-016-0278-x
3032eP Tissue-specific effects of BAP1 loss on metastatic properties of tumor cell lines
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.3647
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat